Research on preterm brain injury treatment recognised
Congratulations to Dr Lindsay Zhou on receiving the 2021 European Society for Paediatric Research Young Investigator Start Up Grant of 10,000 Euros for research on treatment for preterm brain injury.
Dr Zhou's project is investigating the use of umbilical cord blood-derived stem cells as a treatment for preterm brain injury. This includes a world-first clinical trial of autologous cord blood-derived stem cells in extremely preterm infants (the CORDSAFE trial); study of these cells in the laboratory including characterisation and expansion; and examining the neuroprotective effects of these cells in a fetal sheep model of preterm brain injury.
The long-term goals of Dr Zhou's work are to develop a potential cell therapy for the injured neonatal brain, and therefore reduce neuro-disability in survivors of extreme prematurity.
Dr Zhou said, "Delighted to be awarded the grant; this is recognition for the fantastic translational work in perinatal neuroprotection that is occurring at The Ritchie Centre, Monash University and Monash Newborn.".
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.